NCT03767920View on ClinicalTrials.gov

Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

August 1, 2020

Conditions
Cesarean Section
Interventions
DRUG

bupivacaine

TAP block with 20 ml of 0.25% bupivacaine bilaterally

DRUG

dexamethasone

TAP block with 4 mg dexamethasone bilaterally

DRUG

placebo to dexamethasone

TAP block with 4 mg placebo to dexamethasone bilaterally

Trial Locations (1)

81528

Aswan University, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03767920 - Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section | Biotech Hunter | Biotech Hunter